The Catalyst Science Fund launched in 2018 with a 3-year pledge of $1 million annually from biotech company Promega. This fund is designed to hasten impactful innovations in conservation. That’s because a key barrier to the adoption of genomic solutions by the conservation community is the lack of success stories. To that end, we created the Catalyst Science Fund to support early-stage, transformative bio-science research and proof-of-concept projects.
Funds are allocated to drive progress across high value applications. These applications must be identified and vetted as ripe for achieving conservation benefits and must refine and target emerging biotechnologies. Projects and technologies are prioritized that cut-across and can impact multiple conservation challenges. The goal within each focus area is to progress and test technologies and solution viability, to understand and map out what additional work needs to be pursued, and to understand what approaches and areas are worth doubling down on to drive progress and achieve demonstrable impact.
Please note, the Catalyst Science Fund accepts only invited proposals. To be considered for invitation, follow these detailed guidelines.
A species’ genome can reveal ways to better manage populations, natural resources, and entire ecosystems.
Desirable traits like drought resilience and disease resistance may help species thrive into the future.
Cell culture and bio-engineering techniques have the potential to replace the use of wildlife products.
Disruptive non-native species are a difficult and costly problem that calls for innovative intervention.
Restoring Genetic Diversity
Maintaining viable genetic diversity is imperative for the health of shrinking wildlife populations.
Modern biotechnology offers the potential to develop hybrid, ecologically functional proxies of lost species.
Revive & Restore is committed to advancing the science of genetics and biotechnology for conservation applications in a safe, open, and ethical manner. The existing and developing technologies of the genetic rescue tool kit have tremendous potential to address increasingly troubling threats to biodiversity. However, we must also be vigilant to protect against unintended consequences. Revive & Restore evaluates the potential biosecurity risks of all of our projects and, as necessary, seeks safeguards that address any ethical concerns that could be associated with the development and use of genetic technologies for wildlife conservation. All of our Catalyst Science Fund awardees will engage with our Bioethics and Biosecurity panel to receive expert advice on how to evaluate and reduce risks associated with their specific projects.
Catalyst Science Fund Program Manager
Bridget Baumgartner works directly with research teams to advise on proposal submissions, help refine scope-of-work, establish milestones, oversee progress, and review deliverables. She also works closely with Revive & Restore leadership and the Catalyst Science Fund Advisory Council to develop the fund’s investment and grant strategy.
Bridget joined Revive & Restore in January 2019. Bridget brings five years of experience in program creation, development, and management as a contractor to the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA). While at DARPA, Bridget was responsible for driving high-risk, high-reward research and development initiatives in synthetic biology. These were aimed at promoting the use of green technologies to solve big problems. Certain projects in her portfolio also involved counteracting the impacts of climate change and the loss of species diversity. Bridget holds a PhD in Cell and Molecular Biology from Baylor College of Medicine in Houston, TX and a BS in Biochemistry from Stony Brook University of New York.